Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In

Ongoing cases

  • AUTH/2922/12/16 - Assistant Director Medicines Management v Meda
    Description:Conduct of representative
    Case Status:Both the complainant and respondent can appeal
    Last Updated:21/03/2017
  • AUTH/2909/11/16 - Director v Astellas UK
    Description:Clinical trial disclosure (Xtandi)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2908/11/16 - Director v Bayer
    Description:Clinical trial disclosure (Xofigo)
    Case Status:Breach ruled, case report pending
    Last Updated:21/03/2017
  • AUTH/2907/11/16 - Director v Takeda
    Description:Clinical trial disclosure (Vipidia)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2906/11/16 - Director v Novo Nordisk
    Description:Clinical trial disclosure (Tresiba)
    Case Status:Breach ruled, case report pending
    Last Updated:21/03/2017
  • AUTH/2905/11/16 - Director v A Menarini
    Description:Clinical trial disclosure (Spedra)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2904/11/16 - Director v Lundbeck
    Description:Clinical trial disclosure (Selincro)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2903/11/16 - Director v Novo Nordisk
    Description:Clinical trial disclosure (Ryzodeg)
    Case Status:No breach ruled, case report pending
    Last Updated:21/03/2017
  • AUTH/2900/11/16 and AUTH/2910/11/16 - Director v Sanofi
    Description:Clinical trial disclosure (Lyxumia) and (Zaltrap)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2899/11/16 - Director v Aegerion
    Description:Clinical trial disclosure (Lojuxta)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2898/11/16 and AUTH/2901/11/16 - Director v Roche
    Description:Clinical trial disclosure (Kadcyla and Perjeta)
    Case Status:Breach ruled, case report pending - previously displayed in error as no breach outwith the scope of the Code
    Last Updated:22/03/2017
  • AUTH/2896/11/16 - Director v Janssen
    Description:Clinical trial disclosure (Invokana)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2895/11/16 - Director v Boehringer Ingelheim
    Description:Clinical trial disclosure (Giotrif)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2894/11/16 - Director v Mitsubishi Tanabe
    Description:Clinical trial disclosure (BindRen)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2891/11/16 - Ex-employee v Astellas
    Description:Certification and review of materials
    Case Status:No breach, outwith the scope of the Code
    Last Updated:24/01/2017
  • AUTH/2885/11/16 - Anonymous v Gedeon Richter
    Description:Esmya patient support leaflet
    Case Status:Breach ruled, case report pending
    Last Updated:21/12/2016
  • AUTH/2884/10/16 - Clinical commissioning group member v Intrapharm
    Description:Letters to GP practices
    Case Status:Breach ruled, case report pending
    Last Updated:05/01/2017
  • AUTH/2883/10/16 - Voluntary admission by Astellas UK
    Description:Patient support programmes
    Case Status:Breach ruled, report to Appeal Board
    Last Updated:14/03/2017
  • AUTH/2881/10/16 - Anonymous, non-contactable v Shire
    Description:Alleged Shire video on a public website
    Case Status:No breach, outwith the scope of the Code
    Last Updated:22/11/2016
  • AUTH/2858/7/16 - Health Professional v Bayer
    Description:Alleged promotion to the public
    Case Status:No breach, outwith the scope of the Code
    Last Updated:12/10/2016